Laddar...
Late Effects after Chimeric Antigen Receptor T cell Therapy for Lymphoid Malignancies
Chimeric Antigen Receptor T-cell [CAR T] therapy has changed the treatment landscape of relapsed/refractory lymphoid malignancies. With an expanding pool of post CAR T-cell therapy survivors, prevention and management of late toxicities is emerging as an important component of survivorship care. Thi...
Sparad:
| I publikationen: | Transplant Cell Ther |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2020
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8078596/ https://ncbi.nlm.nih.gov/pubmed/33928266 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtct.2020.10.002 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|